BioSpace News Archive

Genetown

Kelonia Therapeutics to Participate in Upcoming Scientific Conferences

Kelonia Therapeutics announced preclinical data from its lead in vivo CAR-T cell therapeutic candidate KLN-1010 in multiple myeloma that will be highlighted at two upcoming scientific conferences.

May 2, 2024
·
2 min read
Business

Invitation to Live Presentation of Senzime’s First Quarter 2024 report

Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime invites investors, analysts, and media to a webcast presentation of the first quarter report for 2024 on May 7, 10:00 CEST.

May 2, 2024
·
1 min read
Veru to Present at the GLP-1 Based Therapeutics Summit

Veru Inc. today announced that the Company has been invited to give a presentation at the GLP-1 Based Therapeutics Summit, taking place May 15-16, 2024, in Philadelphia, PA.

May 2, 2024
·
7 min read
Business

IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share

IRADIMED CORPORAtion announced today its financial results for the three months ended March 31, 2024.

May 2, 2024
·
14 min read
Deals

Corvus Pharmaceuticals Announces Pricing of $30.6 Million Registered Direct Offering

Corvus Pharmaceuticals, Inc. today announced that it has entered into a securities purchase agreement with new and existing investors to raise approximately $30.6 million dollars in aggregate gross proceeds through the sale of shares of its common stock, par value $0.0001 per share.

May 2, 2024
·
5 min read
Business

Akebia Therapeutics to Report First Quarter 2024 Financial Results and Discuss Recent Business Highlights

Akebia Therapeutics ® , Inc. (Nasdaq: AKBA) today announced plans to release its financial results for the first quarter ended March 31, 2024, on Thursday, May 9, 2024, prior to the open of financial markets.

May 2, 2024
·
1 min read
Pharm Country

Establishment Labs Notes Presentation of 4-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2024

Establishment Labs Holdings Inc. noted the presentation today of an update on the Motiva US IDE Study.

May 2, 2024
·
7 min read
Genetown

Ora and Singapore Eye Research Institute Unveil Groundbreaking Partnership to Propel Ophthalmology Innovation Globally

Ora, Inc., the foremost global ophthalmology contract research organization, announced a strategic, exclusive partnership with the Singapore Eye Research Institute, a world-renowned institution for cutting-edge eye research and ophthalmic preclinical studies.

May 2, 2024
·
6 min read
Pharm Country

Outlook Therapeutics® to Present at the Retina World Congress 2024

Outlook Therapeutics, Inc. announced it will present at the 2024 Retina World Congress being held May 9-12, 2024 in Fort Lauderdale, FL.

May 2, 2024
·
2 min read
Lone Star Bio

Moleculin to Host Virtual AML Clinical Day Featuring Internationally Renowned Clinician, Martin S. Tallman, MD, on May 7, 2024

Moleculin Biotech, Inc., a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, announced that it will host a virtual AML Clinical Day on Tuesday, May 7, 2024 at 11:00 AM ET.

May 2, 2024
·
5 min read